16:48 uur 17-11-2015

Gore verkoopt 40 miljoenste implantaat op 40-jarig jubileum

FLAGSTAFF, Ariz.–(BUSINESS WIRE)– W. L. Gore & Associates, Inc. (Gore) heeft vandaag, op zijn 40-jarige jubileum, bekendgemaakt dat het bedrijf wereldwijd 40 miljoen apparaten heeft verkocht.  Gore bereikt deze mijlpaal op het moment dat het zijn nieuwste innovaties en prestaties tentoonstelt op het VEITHsymposium® 2015 in New York.

De afdeling voor medische producten van Gore is opgericht door Bill Gore met de bedoeling een ideale vervanging voor menselijke bloedvaten te ontwikkelen met behulp van GORE-TEX® ePTFE. Veertig jaar later is Gore een marktleider in medische apparatuur, met meer dan 40 miljoen verkochte apparaten voor behandelingen van ieder deel van het lichaam.


Gore Achieves 40 Million Implants Sold Worldwide as it Celebrates 40 Years of Performance

FLAGSTAFF, Ariz.–(BUSINESS WIRE)– W. L. Gore & Associates, Inc. (Gore) today announced in conjunction with its 40th anniversary, it has sold 40 million devices worldwide. The milestones come as the company showcases its latest innovations and achievements for the vascular community at the 2015 VEITHsymposium® in New York.

The medical products division of Gore was formed by Bill Gore with the intent to design an ideal substitute for a human blood vessel using GORE-TEX® ePTFE. Forty years later, Gore is an industry leader in medical devices with more than 40 million devices sold that are designed to treat patients along the entire length of the body.

At VEITHsymposium 2015, Gore is announcing developments to its diverse portfolio of products, including clinical trial developments, as well kicking off the highly anticipated nominations for the 2016-2017 Pioneers in Performance award.

  • The GORE® EXCLUDER® Iliac Branch Endoprosthesis has exceeded 1,000 implants worldwide. This milestone comes only two years after the device received the CE Mark in Europe. The device is currently commercially available in Europe and Australia, in clinical trial in the US, and available through special access in Canada.
  • Gore celebrates its 6th year of the Pioneers in Performance Awards by continuing its tradition of honoring physicians responsible for driving medical innovation and improving clinical and patient outcomes. The Pioneers in Performance Awards recognize physicians for their commitment to advancing vascular and endovascular therapy and minimally invasive treatment options for patients across the globe. These specialties include aortic and lower-limb bypass, and dialysis access surgery. The nominees will be announced on Tuesday evening and voting for the 2016 Pioneers in Performance Awards for North America will open beginning on Wednesday, November 18, 2015.
  • Global vascular thought leaders will reconvene this week at VEITH for an update on the inaugural Gore-sponsored Surgical Bypass Summit. The group is challenging historic beliefs about surgical bypass and whether there needs to be a change in the current treatment paradigm. Content from the inaugural Surgical Bypass Summit is available at www.surgicalbypass.com.

Gore looks towards the future, continuing to improve lives through advanced materials and delivering meaningful innovations that set the standard of performance.

ABOUT VEITHsymposium

Now in its 42nd year, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists, and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies, and new techniques. To register to attend VEITHsymposium, please visit  www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780.


At Gore Medical, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com.

Products listed may not be available in all markets. GORE®, GORE-TEX®, and EXCLUDER® are trademarks of W. L. Gore & Associates. AU1143-EN1 NOVEMBER 2015


Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo, +1 (312) 997-2436

Check out our twitter: @NewsNovumpr